Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T14:17:16.787Z.
Calculation as of: 2026-10-06T14:17:16.787Z.
Quote observation: 2026-10-06T14:15:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e0aae41c25609cbe98cd8c59fbdc20e812e1ea61d6a67e0b8df2c56749153647
EARNINGS YIELD
N/A
Kyverna Therapeutics, Inc.
Market Cap
$376.63M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$372.00M
Earnings Yield
N/A
TTM Avg
0.02%
3Y Avg
0.02%
5Y Avg
0.02%
Market Cap
$380.98M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$396.22M
Earnings Yield
N/A
TTM Avg
11.40%
3Y Avg
11.40%
5Y Avg
11.40%
Market Cap
$355.71M
Earnings Yield
N/A
TTM Avg
0.64%
3Y Avg
0.64%
5Y Avg
0.64%
Market Cap
$350.69M
Earnings Yield
N/A
TTM Avg
2.17%
3Y Avg
3.20%
5Y Avg
4.68%
Market Cap
$407.35M
Earnings Yield
N/A
TTM Avg
8.82%
3Y Avg
5.78%
5Y Avg
5.78%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | $376.63M | N/A | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $372.00M | N/A | 0.02% | 0.02% | 0.02% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $380.98M | N/A | N/A | N/A | N/A |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $396.22M | N/A | 11.40% | 11.40% | 11.40% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $355.71M | N/A | 0.64% | 0.64% | 0.64% |
| Opus Genetics, Inc. (IRD)vs › | $352.14M | N/A | N/A | N/A | N/A |
| Embecta Corp. (EMBC)vs › | $350.92M | 25.02% | 29.71% | 15.15% | 15.10% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $350.69M | N/A | 2.17% | 3.20% | 4.68% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $407.35M | N/A | 8.82% | 5.78% | 5.78% |
| Shoulder Innovations, Inc. (SI)vs › | $408.44M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
